Cargando…
Severe immune thrombocytopenia induced by a single dose of nivolumab in a patient with advanced non-small cell lung cancer
Nivolumab-induced immune thrombocytopenia (ITP) is a rare process with few reported cases. We present a 67-year-old man with advanced non-small cell lung cancer who was hospitalized with severe thrombocytopenia. Physical exam was notable for petechiae across his chest and extremities as well as bull...
Autores principales: | Khorasanchi, Adam, Keresztes, Roger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308713/ https://www.ncbi.nlm.nih.gov/pubmed/32582418 http://dx.doi.org/10.4081/cp.2020.1249 |
Ejemplares similares
-
Immune thrombocytopenia induced by nivolumab in a patient with non-small cell lung cancer
por: Mori, Hidenori, et al.
Publicado: (2019) -
Severe immune thrombocytopenia induced by nivolumab in a patient with metastatic renal cell carcinoma
por: Hata, Shinro, et al.
Publicado: (2020) -
Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia
por: Ansari, Amir M., et al.
Publicado: (2021) -
Duration of nivolumab for pretreated, advanced non–small‐cell lung cancer
por: Geier, Margaux, et al.
Publicado: (2020) -
Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma
por: Sakakibara-Konishi, Jun, et al.
Publicado: (2020)